Literature DB >> 5852886

Treatment of post-herpetic neuralgia.

J M Woodforde, B Dwyer, B W McEwen, F W De Wilde, K Bleasel, T J Connelley, C Y Ho.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1965        PMID： 5852886

Source DB:  PubMed          Journal:  Med J Aust        ISSN： 0025-729X            Impact factor:   7.738


× No keyword cloud information.
  8 in total

Review 1.  Utilization and mechanism of action of tricyclic antidepressants in the treatment of chronic facial pain: a review of the literature.

Authors:  R S Brown; W K Bottomley
Journal:  Anesth Prog       Date:  1990 Sep-Oct

Review 2.  A qualitative systematic review of head-to-head randomized controlled trials of oral analgesics in neuropathic pain.

Authors:  C Peter N Watson; Ian Gilron; Jana Sawynok
Journal:  Pain Res Manag       Date:  2010 May-Jun       Impact factor: 3.037

Review 3.  Post-herpetic neuralgia in older patients. Incidence and optimal treatment.

Authors:  D Bowsher
Journal:  Drugs Aging       Date:  1994-12       Impact factor: 3.923

Review 4.  Anticonvulsants for neuropathic pain syndromes: mechanisms of action and place in therapy.

Authors:  I W Tremont-Lukats; C Megeff; M M Backonja
Journal:  Drugs       Date:  2000-11       Impact factor: 9.546

5.  [Pain therapy in herpes zoster and post-zoster neuralgia.].

Authors:  T Zenz; M Zenz; M Tryba
Journal:  Schmerz       Date:  1994-03       Impact factor: 1.107

6.  [Treatment of chronic pain syndromes with antidepressants.].

Authors:  R Wörz; J Berlin
Journal:  Schmerz       Date:  1989-03       Impact factor: 1.107

Review 7.  Amitriptyline. A review of its pharmacological properties and therapeutic use in chronic pain states.

Authors:  H M Bryson; M I Wilde
Journal:  Drugs Aging       Date:  1996-06       Impact factor: 3.923

8.  Investigational pharmacology for low back pain.

Authors:  Avinash K Bhandary; Gary P Chimes; Gerard A Malanga
Journal:  J Pain Res       Date:  2010-09-06       Impact factor: 3.133
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.